Please assess the completion status of the following clinical trial:

Trial Title: EXOme Rare Cancers in Children (EXOCARE)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* For Patient cancer :~  * Child having developed a cancer combined with a delay of development and\\or an intellectual deficiency before the age of 18 years and followed for a cancer of the child in one of hospital center of the Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'adolescent (SFCE)~ * At least a parent still alive and available to make genetic analyses~* For Parent of cancer patient :~  * Parent whose child meets the criteria of inclusion of Cancer patient~Exclusion Criteria:~* For Cancer patient :~  * Genetic predisposition already identified at the child~ * Absence of histological confirmation~ * Child died without DNA of the available germinal lineage~* For Parent of cancer patient :~  * Parent whose child doesn't meets the criteria of inclusion of Cancer patient

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cancer patient (Type: OTHER): * Collection of blood sample or saliva~* Collection of a tumor sample taken before the participation of the patient in study~* Collection of blood sample if tumor sample is not available
- Parent of cancer patient (Type: OTHER): -Collection of blood sample or saliva

Based on this trial design, predict the completion outcome and termination type (if applicable).